Oculogyric Crisis During Treatment with Aripiprazole

Update Item Information
Identifier 20070213_nanos_posters_077.pdf
Title Oculogyric Crisis During Treatment with Aripiprazole
Creator Erik Kobylarz; Nicholas Schiff; Jacqueline Winterkorn
Affiliation Weill Medical College of Cornell University, New York, NY
Subject Oculogyric Crisis; Dopamine; Aripiprazole; Abilify; Extrapyramidal System
Description We report a case of oculogyric crisis (OGC) associated with aripiprazole (Abilify). Extrapyramidal symptoms (EPS), including oculogyric crisis (OGC), are side effects of neuroleptics, but rarely occur with newer partial dopamine and serotonin agonists. Aripiprazole has desirable clinical properties, i.e. partial agonist at D2 and 5-HT1A, and antagonist of 5-HT2A receptors, appropriately stimulating or blocking D2 receptors.
Date 2007-02-13
Language eng
Format application/pdf
Type Text
Source 2007 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2007: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6gj2qd6
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 181403
Reference URL https://collections.lib.utah.edu/ark:/87278/s6gj2qd6